Literature DB >> 8107746

Easing the suffering caused by sickle cell disease.

O S Platt.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 8107746     DOI： 10.1056/NEJM199403173301110

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

Review 1.  Stroke in children with sickle cell anaemia: aetiology and treatment.

Authors:  C H Pegelow
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

2.  Effect of renin-angiotensin-aldosterone system blocking agents on progression of glomerulopathy in sickle cell disease.

Authors:  Ashley Thrower; Emily J Ciccone; Poulami Maitra; Vimal K Derebail; Jianwen Cai; Kenneth I Ataga
Journal:  Br J Haematol       Date:  2018-11-21       Impact factor: 6.998

3.  Pattern of serum cytokine expression and T-cell subsets in sickle cell disease patients in vaso-occlusive crisis.

Authors:  Bolanle O P Musa; Geoffrey C Onyemelukwe; Joseph O Hambolu; Aisha I Mamman; Albarka H Isa
Journal:  Clin Vaccine Immunol       Date:  2010-02-03

4.  Phase 1 study of the E-selectin inhibitor GMI 1070 in patients with sickle cell anemia.

Authors:  Ted Wun; Lori Styles; Laura DeCastro; Marilyn J Telen; Frans Kuypers; Anthony Cheung; William Kramer; Henry Flanner; Seungshin Rhee; John L Magnani; Helen Thackray
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

Review 5.  Genomic approaches to identifying targets for treating β hemoglobinopathies.

Authors:  Duyen A Ngo; Martin H Steinberg
Journal:  BMC Med Genomics       Date:  2015-07-29       Impact factor: 3.063
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.